FEMY — FEMASYS INC
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1339005 ·
Last close
$4.19
Market Cap
$12.65M
52W High
$12.00
52W Low
$3.77
ADV30
98,394
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 424,889 | 266,283 | -4,223,533 | 846,100 | 16,495,245 | 5,386,041 | 9,205,352 |
| Dec 2025 | 813,387 | 510,262 | -4,622,728 | -3,950,305 | 20,724,177 | 9,266,353 | 14,854,875 |
| Sep 2025 | 729,394 | 435,556 | -3,653,768 | -4,194,821 | 16,290,153 | 4,569,038 | 11,733,902 |
| Jun 2025 | 409,268 | 251,097 | -3,851,566 | -4,585,922 | 13,780,409 | 3,218,067 | 12,272,974 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-18,690,565
Investing CF
$-630,098
Financing CF
$25,135,255
CapEx
$-630,098
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.73
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-145,826,144
Inventory
$5,740,249
Receivables
$616,600
ST Investments
—
EBIT TTM
$-16,735,471
Pretax Income TTM
$-18,626,590
Interest Exp TTM
$1,891,119
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,376,938
EBITDA
$-16,012,144
Free Cash Flow
$-11,760,794
Enterprise Value
$10,936,966
Total Cash
$5,386,041
Total Debt
$4,727,996
Shares Out
3,019,534
Trailing EPS
$-4.80
Book Value
$0.12
ROE
-256.0%
ROA
-68.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 2,293,313 | -17,588,669 | -18,627,887 | 20,724,177 | 14,854,875 | — | -18,690,565 |
| Dec 2024 | 1,629,108 | -17,785,805 | -18,816,628 | 12,445,002 | 10,140,580 | — | -19,444,009 |
| Dec 2023 | 1,071,970 | -14,508,415 | -14,247,124 | 27,755,825 | 9,403,236 | — | -11,280,546 |
| Dec 2022 | 1,206,218 | -11,600,264 | -11,394,170 | 16,895,570 | 1,653,051 | — | -10,731,973 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-5.80
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| SINT | Sintx Technologies, Inc. | $12.90M | $2.08 | — |
| ICU | SeaStar Medical Holding Corp | $12.23M | $3.06 | — |
| CODX | Co-Diagnostics, Inc. | $12.18M | $3.33 | — |
| OSRH | OSR Holdings, Inc. | $13.49M | $0.38 | — |
| UEEC | United Health Products, Inc. | $13.67M | $0.05 | — |
News headlines (Yahoo Finance, 1h cache)
Innoviva Stock Is Up Just 10% This Past Year. Here's Why a Fund Bought $2.5 Million More
2026-05-29 22:55 · Yahoo
Femasys Expands Fertility Care Portfolio in Europe with CE Mark Approval for FemHSG™ Catheter
2026-05-13 13:00 · Yahoo
Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update
2026-05-08 20:05 · Yahoo
Femasys Enables OB/GYNs to Deliver First-Line Fertility Treatment with Initial Commercial Use of FemaSeed® Complete
2026-05-05 13:00 · Yahoo
Femasys Launches FemaSeed® Complete for OB/GYNs at ACOG 2026
2026-04-22 13:00 · Yahoo
Femasys Drives International Growth with Israeli Market Entry for Fertility Portfolio
2026-04-16 13:00 · Yahoo
Femasys Appoints John Canning as Chief Operating Officer to Drive Operational Execution and Advance Commercial Growth
2026-04-01 13:00 · Yahoo
Femasys Announces Financial Results for Year Ended December 31, 2025 and Provides Corporate Update
2026-03-31 20:05 · Yahoo
Femasys Appoints Dr. Kenneth D. Eichenbaum to Board of Directors
2026-03-18 13:00 · Yahoo
Femasys Advances FemBloc Toward U.S. Approval with Initiation of Pivotal Trial Enrollment
2026-03-10 13:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.